Log in to search using one of your social media accounts:

 

How head and neck cancers respond to radiation depends in part on HPV status
People whose head and neck cancers test positive for the human papilloma virus are known to respond more favorably to radiation therapy than those whose cancers are HPV-negative, but an explanation for these differences has remained elusive. Now, UCLA scientists have shown for the first time that radiation treatment transforms cancer cells into head and neck cancer stem cells — which are known to be resistant to radiation therapy — more effectively when the cancer tests negative for HPV. These findings shed light on why some head and neck cancers fare much worse after radiation therapy despite optimum treatment...
Source: UCLA Newsroom: Health Sciences - February 12, 2016 Category: Universities & Medical Training Source Type: news

Obama proposes bigger cancer budget for 2017
President Obama's 2017 budget, released on Monday, proposes $5.9 billion to...Read more on AuntMinnie.comRelated Reading: ASTRO awards grants to researchers ASTRO hails fight on radiation oncology Medicare cuts ASTRO: Proposed MPFS rule would hurt radiation therapy ASTRO lauds CMS CT lung cancer screening decision ASTRO, AANS to launch stereotactic radiosurgery registry (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - February 12, 2016 Category: Radiology Source Type: news

Namibia: Oncology Centre Offers Cutting Edge Cancer Treatment
[Namibia Economist] Windhoek's new Namibian Oncology Centre, equipped with the country's first Elekta digital linear accelerator, has significantly improved treatment options for cancer patients. The centre, built and equipped with funding from Spitz Healthcare Investments, also features chemotherapy, a laboratory, pharmacy and in-patient facilities. The centre's radiation therapy department began treating patients in July 2015, and its oncology pharmacy, chemotherapy unit and sub-acute ward have been operational since Novemb (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - February 12, 2016 Category: African Health Source Type: news

With Studies Like These, We May Never Get AnswersWith Studies Like These, We May Never Get Answers
The design of recent studies on salvage radiation therapy after local recurrence of prostate cancer may preclude any meaningful lessons. Medscape Urology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - February 11, 2016 Category: Consumer Health News Tags: Hematology-Oncology Commentary Source Type: news

Radiation After Lumpectomy in Women ≥70 Still CommonRadiation After Lumpectomy in Women ≥70 Still Common
Despite NCCN guidelines issued in 2004 against the practice, there has been scant decline in the use of postlumpectomy radiation therapy among elderly women with small ER+ breast cancers. Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - February 11, 2016 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news

New Study Finds Interruption of Radiation Therapy Risks Cancer Recurrence
February 9, 2016—(NEW YORK, NY)—Cancer patients who miss two or more radiation therapy sessions have a worse outcome than fully compliant patients, investigators at Montefiore Einstein Center for Cancer Care (MECCC) and Albert Einstein College of Medicine’s NCI–designated Albert Einstein Cancer Center have found. The study, published in the International Journal of Radiation Oncology Biology Physics, suggests that this noncompliance to scheduled treatments may represent a new behavioral biomarker for identifying high-risk patients who require additional interventions to achieve optimal care outcomes...
Source: Einstein News - February 9, 2016 Category: Universities & Medical Training Source Type: news

Interrupted radiation therapy risks cancer recurrence
Patients who miss two or more radiation therapy sessions are at greater risk...Read more on AuntMinnie.comRelated Reading: ASTRO: Shorter RT works for low-risk prostate cancer Shortened RT for prostate cancer may not be better ASTRO: APBI works as well as whole-breast irradiation (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - February 9, 2016 Category: Radiology Source Type: news

Interruption of radiation therapy risks cancer recurrence
Cancer patients who miss two or more radiation therapy sessions have a worse outcome than fully compliant patients, investigators have found. The study evaluated 1,227 patients scheduled for courses of external beam radiation therapy for cancers of the head and neck, breast, lung, cervix uterus or rectum from 2007 to 2012. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - February 9, 2016 Category: Science Source Type: news

Conversion of head and neck cancer cells into radiation-resistant cancer stem cells depends on HPV status, study finds
Head and neck cancers that test positive for the human papilloma virus (HPV) are known to respond more favorably to radiation therapy than those that test HPV-negative, but an explanation for these differences has remained elusive. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - February 9, 2016 Category: Science Source Type: news

New study finds interruption of radiation therapy risks cancer recurrence
(Albert Einstein College of Medicine) Cancer patients who miss two or more radiation therapy sessions have a worse outcome than fully compliant patients, investigators at Montefiore Einstein Center for Cancer Care and Albert Einstein College of Medicine's NCI-designated Albert Einstein Cancer Center have found. The study, published in the International Journal of Radiation Oncology Biology Physics, suggests that this noncompliance to scheduled treatments may represent a new behavioral biomarker for identifying high-risk patients who require additional interventions to achieve optimal care outcomes. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - February 9, 2016 Category: Cancer & Oncology Source Type: news

10 Ways to Improve Your Lung Cancer Survival
What if we knew of something you could do - besides surgery and chemotherapy and radiation therapy - that may improve your survival with lung cancer? Check out these tips. (Source: About.com Lung Cancer)
Source: About.com Lung Cancer - February 6, 2016 Category: Cancer & Oncology Tags: health Source Type: news

Cancer treatment in India one of the best, but doesn't reach everyone
The availability of sophisticated radiation therapy like 3-D CRT and combination of radiation and chemotherapy now account for 80% of the treatments. (Source: The Economic Times)
Source: The Economic Times - February 4, 2016 Category: Consumer Health News Source Type: news

Study Aims to Resolve How To Manage Pre-Cancers of the Breast
This study will provide so many answers to questions that are critical to resolve,” Hwang said. “One of the key features is the assessment of patient-reported outcomes with each approach, as we believe how patients view their disease and their care must be central to any advances in cancer treatment.” The funding award for the DCIS study has been approved pending completion of a business and programmatic review by PCORI staff and issuance of a formal award contract. PHOTO: Shelley Hwang, M.D., Duke Cancer Institute and Duke Department of Surgery. CREDIT: Duke Health. (Source: DukeHealth.org: Duke Health Features)
Source: DukeHealth.org: Duke Health Features - February 4, 2016 Category: Pediatrics Tags: Duke Medicine Source Type: news

Have You Ever Wondered How Radiation Therapy...
Radiation therapy is one of the most common forms of treatment for prostate cancer today. Learn the basics that everyone should know. (Source: About.com Prostate Cancer)
Source: About.com Prostate Cancer - February 4, 2016 Category: Cancer & Oncology Tags: health Source Type: news

Doctors subject early-cancer patients to excessive radiation because it makes them more money
(NaturalNews) In recent years, a new approach to treating breast cancer with radiation therapy has been developed. The introduction of hypofractionated whole breast irradiation (as opposed to conventional whole breast irradiation) has reduced the length of treatment by about half... (Source: NaturalNews.com)
Source: NaturalNews.com - February 1, 2016 Category: Consumer Health News Source Type: news

Does radiation therapy improve survival for women with ductal carcinoma in situ?
(Brigham and Women's Hospital) Investigators from Brigham and Women's Hospital (BWH) and the Dana-Farber Cancer Institute have found that a set of easily measurable risk factors can predict the magnitude of survival benefit offered by radiation therapy following breast cancer surgery. Their results appear online in The Journal of Clinical Oncology on Feb. 1. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - February 1, 2016 Category: Cancer & Oncology Source Type: news

Does Radiation Therapy Improve Survival for Women with Ductal Carcinoma in Situ (DCIS)? Yes...and...No.
Set of risk factors predict which patients with ductal carcinoma in situ (DCIS) will see a survival benefit from radiation therapy after breast cancer surgery. (Source: BWH for Journalists)
Source: BWH for Journalists - February 1, 2016 Category: Research Source Type: news

Does Radiation Therapy Improve Survival for Women with Ductal Carcinoma in Situ (DCIS)? Yes...and...No.
Set of risk factors predict which patients with ductal carcinoma in situ (DCIS) will see a survival benefit from radiation therapy after breast cancer surgery. (Source: BWH News)
Source: BWH News - February 1, 2016 Category: Hospital Management Source Type: news

Does Radiation Therapy Improve Survival for Women with Ductal Carcinoma in Situ (DCIS)? Yes...and...No. (Dana-Farber/Brigham and Women’s Cancer Center)
Approximately 60,000 patients in the United States will receive a diagnosis of ductal carcinoma in situ (DCIS) in 2016. DCIS is not an invasive form of cancer and the 10-year survival rate for women with DCIS is greater than 98 percent. However, incidence of DCIS has increased dramatically over the last three decades, and being able to determine which women are among the small percentage at higher risk of breast cancer recurrence and mortality could help clinicians and patients tailor treatment ... (Source: National Comprehensive Cancer Network)
Source: National Comprehensive Cancer Network - February 1, 2016 Category: Cancer & Oncology Source Type: news

Be Kind to Your Skin During Radiation Treatment
During treatment, radiation therapy may cause skin problems on the breast being radiated that require medical intervention. (Source: About.com Breast Cancer)
Source: About.com Breast Cancer - January 31, 2016 Category: Cancer & Oncology Authors: breastcancer.guide at about.com Tags: health Source Type: news

Newer Treatment May Be Easier on Children with Brain Tumors
Study finds fewer long-term side effects from proton radiotherapySource: HealthDay Related MedlinePlus Pages: Brain Tumors, Cancer in Children, Radiation Therapy (Source: MedlinePlus Health News)
Source: MedlinePlus Health News - January 30, 2016 Category: Consumer Health News Source Type: news

Varian posts mixed Q1 results
Radiation therapy firm Varian Medical Systems reported higher revenues but...Read more on AuntMinnie.comRelated Reading: Varian gets Saudi OK for proton therapy system Varian sees slight revenue increase in 2015 Varian to develop radiotherapy training program in India Varian showcases new products at RSNA 2015 Varian expects drop in earnings for fiscal 2015 (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - January 29, 2016 Category: Radiology Source Type: news

Proton therapy controls common pediatric brain tumor with fewer long-term side effects
(Massachusetts General Hospital) The use of proton radiotherapy to treat the most common malignant brain tumor in children is as effective as standard photon (X-ray) radiation therapy while causing fewer long-term side effects such as hearing loss and cognitive disorders. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - January 29, 2016 Category: Cancer & Oncology Source Type: news

Proton Therapy Controls Common Pediatric Brain Tumor with Fewer Long-Term Side Effects (Massachusetts General Hospital Cancer Center)
The use of proton radiotherapy to treat the most common malignant brain tumor in children is as effective as standard photon (x-ray) radiation therapy while causing fewer long-term side effects such as hearing loss and cognitive disorders, according to a study receiving online publication in Lancet Oncology. The paper from a team led by Massachusetts General Hospital (MGH) investigators describes patient outcomes an average of seven years after proton therapy for medulloblastoma, a fast-growing ... (Source: National Comprehensive Cancer Network)
Source: National Comprehensive Cancer Network - January 29, 2016 Category: Cancer & Oncology Source Type: news

Cancer / Oncology Neurology / Neuroscience Melanoma / Skin Cancer Radiology / Nuclear Medicine Nivolumab combined with radiation therapy may be new treatment option
Nivolumab has been approved by the Food and Drug Administration to treat advanced non-small cell lung cancer, renal cell carcinoma, and melanoma; however, the impact of nivolumab on brain metastases is unclear.01/28/2016 (Source: Kidney Cancer Association)
Source: Kidney Cancer Association - January 28, 2016 Category: Urology & Nephrology Source Type: news

Recommendation to omit radiation therapy after lumpectomy is not frequently implemented
(American College of Surgeons) Nearly two-thirds of US women age 70 or older with stage I breast cancer who undergo lumpectomy and are eligible to safely omit subsequent radiation therapy according to national cancer guidelines still receive this treatment, according to new study results. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - January 27, 2016 Category: Cancer & Oncology Source Type: news

Radiotherapy for Rectal Cancer and Secondary MalignanciesRadiotherapy for Rectal Cancer and Secondary Malignancies
For patients with rectal cancer, there is no link between radiation therapy and a risk for secondary malignancies; in fact, it seems to offer some protection, results from a Dutch study suggest. Medscape Medical News (Source: Medscape Gastroenterology Headlines)
Source: Medscape Gastroenterology Headlines - January 26, 2016 Category: Gastroenterology Tags: Hematology-Oncology News Source Type: news

An invitation to ESTRO 35
(European Society for Radiotherapy and Oncology (ESTRO)) The ESTRO 35 congress will feature new research results in clinical radiation oncology, radiobiology, physics, technology, patient care, radiation therapy and brachytherapy, presented by top doctors, scientists and radiation therapists from all over the world, working together for the benefit of cancer patients.The congress is expected to attract 5,000 delegates from more than 80 countries. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - January 26, 2016 Category: Cancer & Oncology Source Type: news

Nivolumab Combined with Radiation Therapy May Be New Treatment Option for Patients with Melanoma Brain Metastases, Say Moffitt Cancer Center Researchers
President Jimmy Carter's battle with metastatic melanoma to the brain has placed increased attention on management of this disease. President Carter was treated with focused stereotactic radiation to the brain and anti-PD-1 therapy. Researchers at Moffitt Cancer Center recently reported the first series of patients treated with this combined modality approach. They found that radiation therapy combined with the immune-targeting drug nivolumab in melanoma patients with brain metastases is safe an... (Source: National Comprehensive Cancer Network)
Source: National Comprehensive Cancer Network - January 26, 2016 Category: Cancer & Oncology Source Type: news

Childhood cancer survivors face increased risk of metabolic syndrome
(Mary Ann Liebert, Inc./Genetic Engineering News) A new study of metabolic health risk factors in childhood cancer survivors showed increased risk for modifiable factors such as hypertension and overweight/obesity. These factors have been linked to the effects of chemotherapy and radiation therapy and are key contributors to the metabolic syndrome, which increases a patient's risk for cardiovascular disease, as described in an article in Journal of Adolescent and Young Adult Oncology (JAYAO). (Source: EurekAlert! - Biology)
Source: EurekAlert! - Biology - January 25, 2016 Category: Biology Source Type: news

Study Pinpoints Best Timing for Rectal Cancer Surgery
Patients who had procedure 8 weeks after chemo and radiation therapy had best survival rates (Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - January 21, 2016 Category: Cancer & Oncology Authors: webmaster at doctorslounge.com Tags: Family Medicine, Nursing, Oncology, Surgery, News, Source Type: news

What's the Best Timing for Rectal Cancer Surgery?
Patients who had procedure 8 weeks after chemo and radiation therapy had best survival rates (Source: WebMD Health)
Source: WebMD Health - January 21, 2016 Category: Consumer Health News Source Type: news

Study Pinpoints Best Timing for Rectal Cancer Surgery
Patients who had procedure 8 weeks after chemo and radiation therapy had best survival rates Source: HealthDay Related MedlinePlus Pages: Colorectal Cancer, Surgery (Source: MedlinePlus Health News)
Source: MedlinePlus Health News - January 21, 2016 Category: Consumer Health News Source Type: news

Study Pinpoints Best Timing for Rectal Cancer Surgery
Patients who had procedure 8 weeks after chemo and radiation therapy had best survival rates (Source: Cancercompass News: Other Cancer)
Source: Cancercompass News: Other Cancer - January 21, 2016 Category: Cancer & Oncology Source Type: news

North America continues to dominate radiotherapy market
North America will hold the largest share of the global radiotherapy market,...Read more on AuntMinnie.comRelated Reading: South Korean proton therapy market to grow IMV: Technology drives radiation therapy market Report: Radiation therapy market regains stability Report: U.S. therapeutic radiopharma market set for growth GlobalData predicts worldwide radiotherapy device growth (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - January 20, 2016 Category: Radiology Source Type: news

Diabetes a Late Effect of Abdominal Radiation?Diabetes a Late Effect of Abdominal Radiation?
Childhood cancer survivors treated with abdominal radiation therapy are at risk for subsequent diabetes, possibly caused by early subclinical derangements of glucose and insulin, new research shows. Medscape Medical News (Source: Medscape Pathology Headlines)
Source: Medscape Pathology Headlines - January 19, 2016 Category: Pathology Tags: Hematology-Oncology News Source Type: news

Be Kind to Your Skin During Radiation
During treatment, radiation therapy may cause skin problems on the breast being radiated that require medical intervention. (Source: About.com Breast Cancer)
Source: About.com Breast Cancer - January 16, 2016 Category: Cancer & Oncology Authors: breastcancer.guide at about.com Tags: health Source Type: news

How Radiation Therapy for Cervical Cancer is Done
Radiation therapy is a common treatment method for cervical cancer. Find out about the different variations of this procedure and its side effects. (Source: About.com Cervical Cancer)
Source: About.com Cervical Cancer - January 14, 2016 Category: Cancer & Oncology Authors: cervicalcancer.guide at about.com Tags: health Source Type: news

iCAD acquires VuCOMP cancer portfolio
Computer-aided detection (CAD) and radiation therapy firm iCAD has completed...Read more on AuntMinnie.comRelated Reading: iCAD wins 8 Xoft contracts worldwide iCAD previews new tomosynthesis software at RSNA 2015 iCAD launches cervical applicator for Xoft Axxent VuCOMP completes structured reporting for CAD DBT VuCOMP sells breast density software to iCAD VuCOMP submits PMA for breast tomo CAD (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - January 13, 2016 Category: Radiology Source Type: news

HeartWare taps ex-Medtronic exec Oesterle for board | Personnel Moves
HeartWare International (NSDQ:HTWR) is looking to get in on Dr. Stephen Oesterle, an Ex-Medtronic (NYSE:MDT) exec who moved to the venture capital firm New Enterprise Associates last Sept., saying this week that it expanded its board to accommodate Oesterle. Oesterle will officially come aboard on Jan. 18, and his appointment included an expansion to HeartWare’s board from 8 to 9 members, according to the Framingham, Mass.-based company. “Dr. Oesterle has extensive experience in the development of emerging medical therapies, with a broad strategic perspective in corporate management, as well as the clinica...
Source: Mass Device - January 13, 2016 Category: Medical Equipment Authors: Fink Densford Tags: Business/Financial News AdvaMed Avita Medical Ltd. Command Medical Products Haemonetics HeartWare International Inc. ICU Medical Inc. InnAVasc Integrity Applications IsoRay Medtronic New Enterprise Associates Personnel Moves Zelt Source Type: news

Early Trial Shows Injectable Agent Illuminates Cancer During Surgery
Contact: Samiha KhannaPhone: 919-419-5069Email: samiha.khanna@duke.eduhttps://www.dukemedicine.org EMBARGOED FOR RELEASE until 2 p.m. (ET) Wednesday, Jan. 6, 2016 DURHAM, N.C. -- Doctors at Duke Medicine have tested a new injectable agent that causes cancer cells in a tumor to fluoresce, potentially increasing a surgeon’s ability to locate and remove all of a cancerous tumor on the first attempt. The imaging technology was developed through collaboration with scientists at Duke, the Massachusetts Institute of Technology (MIT) and Lumicell Inc. According to findings published January 6 in Science Translational Medicin...
Source: DukeHealth.org: Duke Health Features - January 6, 2016 Category: Pediatrics Tags: Duke Medicine Source Type: news

Top 10 Mesothelioma News Stories of 2015
We're making progress in the fight against malignant pleural mesothelioma. Doctors are treating it more aggressively. New drugs are emerging. Survivors are living longer. Therapies are becoming more precise and individualized. And specialty centers are becoming more prominent and comprehensive. Even the highly criticized U.S. Department of Veterans Affairs (VA) is taking it more seriously now. There is growing hope on the horizon. Here are the most prominent stories of 2015, providing a glimpse of what will come in 2016. FDA Approves Keytruda and Opdivo for Lung Cancer The U.S. Food and Drug Administrati...
Source: Asbestos and Mesothelioma News - December 31, 2015 Category: Environmental Health Authors: Tim Povtak Tags: Treatment & Doctors Source Type: news

When Breast Cancer Comes Back
By Stacy Simon Thanks to improvements in breast cancer treatment over the past several decades, the end of treatment for many women means their cancer is gone. A successful end to treatment can be both stressful and exciting. You’re likely to be relieved to finish treatment, but you may find it hard not to worry about cancer coming back. This is very common among people who have had cancer. Steps for staying as healthy as possible include eating right, getting regular exercise, staying away from tobacco, limiting alcohol, and getting recommended screening tests. But sometimes, even when you’ve done everything w...
Source: American Cancer Society :: News and Features - December 28, 2015 Category: Cancer & Oncology Tags: Breast Cancer Coping with Cancer Source Type: news

Diagnosed With Prostate Cancer, Now What: A New Study Shows That Surgery Is the Best Option
With prostate cancer being one of the leading cancers in men, finding the best way to treat it has become increasingly important. A new study points to why surgery might be the best long term treatment option, especially for men with localized prostate cancer. Researchers from Odette Caner Centre, Sunnybrook Research Institute (University of Toronto, Canada) conducted a meta-analysis of 19 studies comparing the success/survival rates of surgery vs. radiation. All in all, this added up to about 120,000 men who received either surgery or radiation as treatment for their localized prostate cancer. What researchers found was t...
Source: Healthy Living - The Huffington Post - December 17, 2015 Category: Consumer Health News Source Type: news

Study shows multiple-dose, targeted radiation more effective for treating pituitary tumors
(Houston Methodist) A recent patient study at Houston Methodist Hospital proved that multiple small doses of highly focused radiation therapy is safer and more effective than a single larger dose of radiation at destroying pituitary gland tumors. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - December 16, 2015 Category: Cancer & Oncology Source Type: news

Prostate cancer surgery a better bet on balance than radiation therapy, study finds
PROSTATE cancer patients are more likely to survive if they undergo surgery rather than radiation, a study found. (Source: Daily Express - Health)
Source: Daily Express - Health - December 15, 2015 Category: Consumer Health News Source Type: news

'Suicide Gene Therapy' Plus Radiation Fights Prostate Cancer: Study
Patients' cancer cells modified to prompt immune system to attack them, researchers explained Source: HealthDay Related MedlinePlus Pages: Genes and Gene Therapy, Prostate Cancer, Radiation Therapy (Source: MedlinePlus Health News)
Source: MedlinePlus Health News - December 14, 2015 Category: Consumer Health News Source Type: news

Smoking Ups Late Effects of Breast Cancer Radiation Smoking Ups Late Effects of Breast Cancer Radiation
Smokers who quit at the time of radiation therapy for breast cancer can significantly lower their risk for late pulmonary, cardiac complications. Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - December 14, 2015 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news

Promising cancer therapy advanced by chemical explanation
Radiation therapy: A chilling word that creates images of burn-injuries where the cancer killing ray went through the skin. For decades research hospitals have been investigating the alternative method Hadron therapy, or particle therapy, where runaway cells are bombarded with 'naked' atomic nuclei or protons. When the particles pass through sick cells the collision creates chemical reactions preventing further cell division. Now researchers have discovered an unknown reaction caused by the therapy. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - December 14, 2015 Category: Science Source Type: news